Prostate Cancer Clinical Trial
Decipher Genomics Resource for Intelligent Discovery
Summary
To prospectively evaluate the utility of genomic expression data as a tool to better characterize the tumors of individual patients, and to understand how genomic information from individual patients undergoing routine clinical testing can be used in population-level analysis to improve treatment and outcomes.
Full Description
Observational study involving the release of tumor genome-wide expression data generated by the Decipher assay which will be linked to clinical treatment and outcome data for patients in whom Decipher clinical testing was performed. The GRID database population will be used to characterize the genomics of cancer and discover or validate gene expression signatures that may be useful for understanding of the biology of the disease and implementing precision medicine approaches for cancer patients.
Eligibility Criteria
Inclusion Criteria:
Subjects that have had a Decipher clinical test
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Indian Wells California, 92210, United States
Los Angeles California, 90048, United States
San Francisco California, 94158, United States
Miami Florida, 33136, United States
Tampa Florida, 33612, United States
Evanston Illinois, 60208, United States
Baltimore Maryland, 21287, United States
Boston Massachusetts, 02115, United States
Royal Oak Michigan, 48067, United States
Philadelphia Pennsylvania, 19107, United States
How clear is this clinincal trial information?